Search company, investor...
Gritstone Oncology company logo

Gritstone Oncology

gritstoneoncology.com

Founded Year

2015

Stage

IPO | IPO

Total Raised

$194.7M

Date of IPO

9/28/2018

Market Cap

0.22B

Stock Price

2.69

About Gritstone Oncology

Gritstone Oncology (NASDAQ Global: GRTS) is a personalized cancer immunotherapy company that is advancing the field of immuno-oncology to fight cancer in patients with the most difficult-to-treat tumors. The company develops potent, next-generation, personalized immunotherapies that harness the power of the patient's own immune system to specifically recognize non-self targets displayed by the tumor (called tumor-specific neoantigens) to effectively destroy tumor cells.

Headquarters Location

5858 Horton Street Suite 210

Emeryville, California, 94608,

United States

510-871-6100

Missing: Gritstone Oncology's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Gritstone Oncology's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Gritstone Oncology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Gritstone Oncology is included in 3 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Gritstone Oncology Patents

Gritstone Oncology has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Vaccines
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/8/2018

11/22/2022

Molecular biology, Immune system, Genetics, Clusters of differentiation, Biotechnology

Grant

Application Date

5/8/2018

Grant Date

11/22/2022

Title

Related Topics

Molecular biology, Immune system, Genetics, Clusters of differentiation, Biotechnology

Status

Grant

Latest Gritstone Oncology News

Gritstone Oncology (GRTS) Stock Increases Over 10%: Details

Oct 31, 2022

The stock price of Gritstone Oncology (GRTS) increased by over 10% intraday today. This is why. The stock price of Gritstone Oncology (GRTS) increased by over 10% intraday today. Why: Research report Analyst firm: Piper Sandler Piper Sandler analysts adjusted the rating while noting that Gritstone’s proprietary EDGE platform is able to identify immunogenic neoantigens that the company delivers with a Chimpanzee Adenovirus (ChAd) prime and self-amplifying mRNA (samRNA) booster. And Gritstone is conducting a Phase II/III trial of personalized cancer vaccine GRANITE in microsatellite stable-colorectal cancer (MSS-CRC) with preliminary data in the second half of 2023. Trending on Pulse 2.0

Gritstone Oncology Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Gritstone Oncology Rank

Gritstone Oncology Frequently Asked Questions (FAQ)

  • When was Gritstone Oncology founded?

    Gritstone Oncology was founded in 2015.

  • Where is Gritstone Oncology's headquarters?

    Gritstone Oncology's headquarters is located at 5858 Horton Street, Emeryville.

  • What is Gritstone Oncology's latest funding round?

    Gritstone Oncology's latest funding round is IPO.

  • How much did Gritstone Oncology raise?

    Gritstone Oncology raised a total of $194.7M.

  • Who are the investors of Gritstone Oncology?

    Investors of Gritstone Oncology include The Column Group, Versant Ventures, Clarus, Frazier Healthcare Partners, Google Ventures and 9 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.